Adenocarcinoma of the Pancreas Completed Phase 1 / 2 Trials for Conatumumab (DB11646)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00630552QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerTreatment